Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.0234.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 28.44% | 45.11% | 63.37% | 60.81% | 57.53% |
| Total Other Revenue | -- | -- | -- | -- | -90.00% |
| Total Revenue | 28.44% | 45.11% | 63.37% | 60.81% | 57.50% |
| Cost of Revenue | 36.88% | 39.91% | 48.34% | 40.09% | 38.73% |
| Gross Profit | 22.99% | 48.66% | 74.39% | 77.24% | 72.60% |
| SG&A Expenses | 21.18% | 50.97% | 77.48% | 78.21% | 69.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.48% | 47.75% | 67.19% | 63.11% | 56.76% |
| Operating Income | -18.87% | -73.34% | -106.45% | -85.42% | -50.38% |
| Income Before Tax | -1,468.27% | -3,462.28% | 43.53% | 60.14% | 87.68% |
| Income Tax Expenses | 111.02% | 132.98% | -2,798.33% | -2,836.67% | -2,524.29% |
| Earnings from Continuing Operations | -2,592.42% | -738.63% | 62.25% | 80.10% | 107.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,592.42% | -738.63% | 62.25% | 80.10% | 107.78% |
| EBIT | -18.87% | -73.34% | -106.45% | -85.42% | -50.38% |
| EBITDA | -12.41% | -76.96% | -109.86% | -66.28% | -27.84% |
| EPS Basic | -40,100.00% | -1,178.23% | 71.11% | 82.21% | 99.67% |
| Normalized Basic EPS | -13.89% | -46.14% | -52.37% | -42.26% | -16.76% |
| EPS Diluted | -3,768.75% | -1,556.38% | 70.31% | 81.22% | 96.82% |
| Normalized Diluted EPS | -15.84% | -49.02% | -50.28% | -40.15% | -14.80% |
| Average Basic Shares Outstanding | 16.36% | 15.70% | 23.66% | 24.99% | 26.54% |
| Average Diluted Shares Outstanding | 14.55% | 13.82% | 25.45% | 26.89% | 28.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
